KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Ambev (ABEV) EPS (Basic) (2016 - 2025)

Historic EPS (Basic) for Ambev (ABEV) over the last 14 years, with Q3 2025 value amounting to $17.4 billion.

  • Ambev's EPS (Basic) fell 1811.89% to $17.4 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $17.4 billion, marking a year-over-year decrease of 1811.89%. This contributed to the annual value of $46.6 billion for FY2024, which is 1008.04% down from last year.
  • According to the latest figures from Q3 2025, Ambev's EPS (Basic) is $17.4 billion, which was down 1811.89% from $8.3 billion recorded in Q2 2025.
  • Over the past 5 years, Ambev's EPS (Basic) peaked at $22.3 billion during Q4 2024, and registered a low of $3.8 billion during Q3 2022.
  • For the 5-year period, Ambev's EPS (Basic) averaged around $13.2 billion, with its median value being $15.5 billion (2023).
  • Per our database at Business Quant, Ambev's EPS (Basic) tumbled by 3822.8% in 2021 and then surged by 24078.86% in 2024.
  • Over the past 5 years, Ambev's EPS (Basic) (Quarter) stood at $17.2 billion in 2021, then plummeted by 37.36% to $10.8 billion in 2022, then soared by 43.88% to $15.5 billion in 2023, then soared by 43.49% to $22.3 billion in 2024, then decreased by 22.04% to $17.4 billion in 2025.
  • Its last three reported values are $17.4 billion in Q3 2025, $8.3 billion for Q2 2025, and $20.6 billion during Q1 2025.